Trademark: MULTIPLE PATHWAYS, MULTIPLE TARGETS: DRUG DISCOVERY FOR CELGENE
Put your brand on the blockchain and timestamp its proof of existence at wikitrademarks.io
Track updates on MULTIPLE PATHWAYS, MULTIPLE TARGETS: DRUG DISCOVERY FOR CELGENE
Mark Identification
MULTIPLE PATHWAYS, MULTIPLE TARGETS: DRUG DISCOVERY FOR CELGENE
Proof of use for MULTIPLE PATHWAYS, MULTIPLE TARGETS: DRUG DISCOVERY FOR CELGENE
We do not have any records of a proof of use for MULTIPLE PATHWAYS, MULTIPLE TARGETS: DRUG DISCOVERY FOR CELGENE at this moment.
Click here to add a proof of use for MULTIPLE PATHWAYS, MULTIPLE TARGETS: DRUG DISCOVERY FOR CELGENE
Possible trademark infringements of MULTIPLE PATHWAYS, MULTIPLE TARGETS: DRUG DISCOVERY FOR CELGENE
Basic Information about MULTIPLE PATHWAYS, MULTIPLE TARGETS: DRUG DISCOVERY FOR CELGENE
- Serial Number
- 76413439
- Filing Date
- 29 May 2002
- Registration Number
- 2911994
- Registration Date
- 21 Dec 2004
- Mark Drawing Code
- 1
Classifications
Declare the trademark use of MULTIPLE PATHWAYS, MULTIPLE TARGETS: DRUG DISCOVERY FOR CELGENE on the blockchain with WikiTrademarks.io.
- First use of MULTIPLE PATHWAYS, MULTIPLE TARGETS: DRUG DISCOVERY FOR CELGENE anywhere
- MULTIPLE PATHWAYS, MULTIPLE TARGETS: DRUG DISCOVERY FOR CELGENE was first used on 18 May 2002 for the primary classification of goods and services, international, 042 (Computer, scientific & legal)
- First use in commerce
- There is no first use of this trademark in commerce detected yet.
- Status Code
- 6
- International Code
- 042
- US Codes
- 100; 101
Who owns MULTIPLE PATHWAYS, MULTIPLE TARGETS: DRUG DISCOVERY FOR CELGENE?
Correspondent
- Marilyn F. Kelly
- Bristol-Myers Squibb Company
- Trademark Dept., Mailstop D.4243
- PO BOX 4000
Put your brand on the blockchain and timestamp its proof of existence at Wikitrademarks.io
Track updates on MULTIPLE PATHWAYS, MULTIPLE TARGETS: DRUG DISCOVERY FOR CELGENE